NZME Updates FY23 Guidance
AUCKLAND, 7 November 2023: NZME Limited (NZX: NZM, ASX: NZM) (“NZME”) notes that the economic environment over the past year has been challenging.   
Advertising revenue for the first half of 2023 was down 7 percent year on year.  Given this, NZME provided an update in August that it expected to achieve EBITDA at the bottom of the guidance range of $59 million to $64 million for 2023. 
The second half has seen improvement in business confidence, but this is not yet consistently reflected in advertising revenue results:
• Quarter 3 advertising revenue was down 2 percent year on 
        year 
• Quarter 4 started with October advertising revenue growth 
        of 1 percent year on year
• November (the largest revenue month of the year) and 
        December are currently pacing slower, with a number of 
        customer campaigns being cancelled or deferred until 2024
 
Given the current advertising revenue volatility in the market, NZME amends its guidance for EBITDA to be between $57 million and $59 million for 2023.
NZME is continuing its transition to a digital-led business and will update its shareholders at its Investor Day on 15 November 2023. 
ENDS
Authorised by the Board of NZME Limited.
For further information:
For media 
Kelly Gunn
GM Communications
+64 27 213 5625
[email protected]
For investors
David Mackrell
Chief Financial Officer
+64 21 311 911
[email protected] 
        Market leader Fisher & Paykel Healthcare was up 25c.
From wannabe Google challenger to now selling off its last business to escape debt.
                    Looks to grow at pace of economy, invests in business.
                    To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details